Chiesi Farmaceutici is a research-focused international group, with nearly 80 years of experience headquartered in Parma, Italy.


Chiesi researches, develops and commercializes innovative pharmaceutical solutions in the respiratory therapeutics and specialist medicine areas.


In 2015, Chiesi achieved sales of over 1.4 billion Euros.

The Chiesi Group employs approximately 4,400 people, 500 of which are dedicated to R&D activities.


Its R&D centers in Parma (Italy), Paris (France), Rockville (USA), Chippenham (UK) and the Swedish and Danish R&D team of the controlled company Zymenex, integrate their efforts to advance Chiesi's pre-clinical, clinical and registration programs.


For more information, please visit

 Chiesi Ventures invests independently but maintains strategic connections to the Chiesi Group.

"Race to the future"

Published on Aug 1, 2012

"The New R&D Center"

Published on Aug 1, 2012

"Our values"

Published on Aug 1, 2012